Literature DB >> 8982375

Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

H Kosmehl1, A Berndt, D Katenkamp.   

Abstract

This review deals with biological and pathological aspects of various isoforms of the matrix molecules fibronectin and laminin. They are generated by different molecular mechanisms: ED-A+ and ED-B+ fibronectin by alternative splicing of pre mRNA, de novo-glycosylated fibronectin by alternative post-translational O-linked glycosylation of the IIICS region, and the laminin isoforms by exchange of single chains of the heterotrimeric molecule. In contrast to the "common" fibronectin, the distribution of ED-B+ and de novo-glycosylated fibronectin is restricted to embryonic tissues; they subsequently reappear in granulation tissue, in fibrosing processes and in tumour stroma. The expression of these so-called oncofetal fibronectins is stimulated by growth factors (TGF beta). The association of the ED-B+ fibronectin with proliferative activity and newly formed vessels identifies this fibronectin variant as a marker of cellular activity in the process of fibrosis and as a suitable agent for the evaluation of tumour angioneogenesis. Initial results suggest a correlation between the amount of ED-B+ and de novo-glycosylated fibronectin in tumour stroma and the behaviour of carcinomas with regard to their invasiveness and propensity for metastatic dissemination. The current nomenclature of the laminin molecule family is presented. The laminin chain constitution of basement membranes switches from embryonic or proliferatively active to adult terminally differentiated tissues [disappearance of the laminin beta 2 (s) chain] and depends on the tissue type. The discrepancy between the loss of basement membranes (multiple basement membrane defects) in carcinomas and the recently reported increased laminin chain synthesis in these tumours may be explained by abundant laminin chain deposition outside the basement membrane in the carcinoma invasion front, possibly associated with enhanced adhesion of budding tumour cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982375     DOI: 10.1007/bf00198435

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  124 in total

1.  Detection of sequence variants in the gene encoding the beta 3 chain of laminin 5 (LAMB3).

Authors:  L Pulkkinen; J A McGrath; A M Christiano; J Uitto
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

2.  Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing.

Authors:  L F Brown; D Dubin; L Lavigne; B Logan; H F Dvorak; L Van de Water
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

Review 3.  The laminin family.

Authors:  K Tryggvason
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

4.  Abnormal localization of laminin subunits in muscular dystrophies.

Authors:  Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

5.  Basement membrane proteins kalinin and nicein are structurally and immunologically identical.

Authors:  M P Marinkovich; P Verrando; D R Keene; G Meneguzzi; G P Lunstrum; J P Ortonne; R E Burgeson
Journal:  Lab Invest       Date:  1993-09       Impact factor: 5.662

6.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

7.  Fetal fibronectin in patients at increased risk for premature birth.

Authors:  M P Nageotte; D Casal; A E Senyei
Journal:  Am J Obstet Gynecol       Date:  1994-01       Impact factor: 8.661

8.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Human laminin M chain: epitope analysis of its monoclonal antibodies by immunoscreening of cDNA clones and tissue expression.

Authors:  H Hori; T Kanamori; T Mizuta; N Yamaguchi; Y Liu; Y Nagai
Journal:  J Biochem       Date:  1994-12       Impact factor: 3.387

10.  Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.

Authors:  C Ffrench-Constant; L Van de Water; H F Dvorak; R O Hynes
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  34 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas.

Authors:  P Dehan; D Waltregny; A Beschin; A Noel; V Castronovo; K Tryggvason; J De Leval; J M Foidart
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins.

Authors:  Elisa Ventura; Francesca Sassi; Sara Fossati; Arianna Parodi; William Blalock; Enrica Balza; Patrizia Castellani; Laura Borsi; Barbara Carnemolla; Luciano Zardi
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

4.  Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin-C in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive tumor front.

Authors:  Marcus Franz; Torsten Hansen; Petra Richter; Laura Borsi; Frank-D Böhmer; Peter Hyckel; Peter Schleier; Detlef Katenkamp; Luciano Zardi; Hartwig Kosmehl; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2005-12-13       Impact factor: 4.304

5.  Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin.

Authors:  Patrizia Castellani; Laura Borsi; Barbara Carnemolla; Attila Birò; Alessandra Dorcaratto; Giuseppe L Viale; Dario Neri; Luciano Zardi
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  [Clinical and immunohistochemical findings of intra- and extraoral angiosarcomas].

Authors:  Oliver Driemel; A Berndt; A Hartmann; U D Mueller-Richter; R Bauer; T E Reichert; H Kosmehl
Journal:  Mund Kiefer Gesichtschir       Date:  2006-07

7.  Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid.

Authors:  V M Manzano; J C Muñoz; J R Jiménez; M R Puyol; D R Puyol; M Kitamura; F J Cazaña
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

8.  Rotavirus enterotoxin NSP4 binds to the extracellular matrix proteins laminin-beta3 and fibronectin.

Authors:  J A Boshuizen; J W A Rossen; C K Sitaram; F F P Kimenai; Y Simons-Oosterhuis; C Laffeber; H A Büller; A W C Einerhand
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8.

Authors:  Elisa Ventura; Francesca Sassi; Arianna Parodi; Enrica Balza; Laura Borsi; Patrizia Castellani; Barbara Carnemolla; Luciano Zardi
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

Review 10.  New radiotracers for imaging of vascular targets in angiogenesis-related diseases.

Authors:  Hao Hong; Feng Chen; Yin Zhang; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2014-07-30       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.